search

VALONTAN * 10CPR RIV 100MG

  • RECORDATI SpA
  • 003452024
Features:


Indicated in case of nausea and vomiting.


Indicated in case of seasickness, motion sickness and train sickness.


Deductible over-the-counter drug.


Indicated from 12 years of age.


















info_outline View product sheet
Final Price €9.30
Quantity
check_circle Available (19 Items)
48h

redeem loyalty points

By buying this product you can collect up to 9 loyalty points that can be converted into a voucher. More info

  Convenient and safe payments

Even with a credit card

  Shipping in 48h-72h all over the world

FREE in Italy over € 39.90

  Fast returns

14 days to reconsider

  Pharmaceutical experience

Always at your service

Other products Others products at unbeatable price

RECORDATI SpA

Discover all products

VALONTAN * 10CPR RIV 100MG

Therapeutic indications

Prevention and treatment of nausea, vomiting and vertigo, typical of naupathias (seasickness, car, train, plane sickness).

Dosage and method of use

AdultsIn naupathy (seasickness, car, train, plane sickness), nausea and vomiting can be controlled with a single dose of half a tablet of VALONTAN Adult (50 mg), the effect of which lasts approximately 4 hours. ; this dose, if necessary, can be repeated, for prevention purposes, every 4 hours (3 tablets in 24 hours). Do not exceed the recommended dose. Do not use for prolonged treatments.

Contraindications

Hypersensitivity to the active substance, to other antihistamines, or to any of the excipients. Contraindicated in children and adolescents. Contraindicated during pregnancy and lactation.

Side effects

The following undesirable effects have been reported following treatment with VALONTAN Adults:

System organic classification according to MedDRA More frequent side effects Frequent side effects Less frequent side effects
Metabolism and nutrition disorders   Anorexia  
Psychiatric disorders     Insomnia, Euphoria
Nervous system disorders Sedation, Somnolence Headache Vertigo, Tremors, Convulsions
Eye disorders   Disorders of accommodation  
Cardiac pathologies     Tachycardia
Vascular pathologies     Hypotension
Gastrointestinal disorders   Dry mouth, Nausea  
Skin and subcutaneous tissue disorders   Photosensitivity, Skin reaction on allergic basis  
Renal and urinary disorders   Disorders of urination  
General disorders and administration site conditions     Asthenia
Reporting of suspected adverse reactions

Reporting of suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit / risk ratio of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting systemhttps://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Special warnings

Using antihistamines at the same time as certain antibiotics or other ototoxic drugs can mask the early signs of ototoxicity, which can only reveal itself when the damage is irreversible. Use with caution in subjects suffering from glaucoma, prostatic hypertrophy, other urinary retention syndromes, intestinal obstruction, arterial hypertension, cardiovascular disease, bronchial asthma, chronic bronchitis or emphysema, hyperthyroidism. The medicine can exacerbate seizure disorders. It should therefore be used with great caution in subjects suffering from epilepsy.VALONTAN Adult contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.

Pregnancy and breastfeeding

VALONTAN Adult is contraindicated during pregnancy and lactation (see section 4.3). In breastfeeding patients it is necessary to decide whether to give up breastfeeding the baby and start the treatment or, vice versa, continue breastfeeding avoiding the administration of the product.

Expiration and retention

None.

Interactions with other drugs

During treatment, avoid the simultaneous use of alcoholic beverages and antidepressant, hypnotic, sedative or tranquilizing drugs, in order to prevent any additive sedation phenomena (see also section 4.7).

Overdose

In case of overdose consult your doctor immediately. Sleepiness is the most usual symptom of overdosing. Toxic doses can produce: convulsion, coma and respiratory depression. If necessary, implement symptomatic therapy. When needed, respiratory assistance.

Active principles

Each coated tablet contains:Active principleDimenhydrinate 100 mg Excipient with known effect: each coated tablet contains 16 mg of sucrose. For the full list of excipients, see section 6.1.

Excipients

Sucrose, colloidal silica, magnesium stearate, corn starch.Coating components: acrylic resin (Eudragit), talc.

RECORDATI SpA
003452024
19 Items

Data sheet

Packaging
100 mg 10 tablets
Product Type
HUMAN DRUG
ATC code
R06AA11
ATC description
Dimenhydrinate (ATC R06AA02 cleaves: products containing dimenhydrinate / diphenhydramine theoclate go into the new ATC. Products containing diphenhydramine chloride remain in R06AA02.
Therapeutic Group
Antiemetics
Active principle
dimenhydrinate (DC.IT) (FU)
Class
C.
Pharmaceutical form
coated tablet
Type of Administration
oral
Container
blister
Quantity
10 coated tablets
Capacity
100 milligrams
Quantity of the Active Ingredient
100MG
Recipe required
OTC - self-medication medicine